Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 135 - Multiplicity, Missing Data and Other Topics
Type: Contributed
Date/Time: Monday, August 9, 2021 : 1:30 PM to 3:20 PM
Sponsor: Biopharmaceutical Section
Abstract #318124
Title: Indirect Treatment Comparison with Evidences of Different Sources and Quality
Author(s): Tianming Gao* and Hongwei Wang and Weili He and Linyu Shi
Companies: AbbVie and AbbVie and AbbVie and AbbVie
Keywords: indirect treatment comparison; network meta-analysis
Abstract:

Network meta-analysis and indirect treatment comparison are playing an increasingly important role in pharmaceutical industry for evidenced-based decision making. There are well-established methods to synthesize evidence from aggregated data (AD) from randomized clinical trial (RCT). Methods have also been proposed to combine the individual patient data (IPD) with AD. With the wide availability of real-world data for clinical research, evidence synthesis across data from randomized and non-randomized studies is another active research area. In this presentation, we will compare methodologies for evidence synthesis from different sources and levels, the key differences between the methodologies in terms of underlying assumptions, strength, and limitation. Tool availability and performance of these methods will also be reported. This is to provide a better understanding of the current landscape of network meta-analysis in evidence synthesizing across different data sources with varying quality, and recommend best practices to address the challenges.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2021 program